Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2019, Article ID 1780567, 11 pages
https://doi.org/10.1155/2019/1780567
Research Article

Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)

1Jiangsu Institute of Clinical Immunology, First Affiliated Hospital of Soochow University, Suzhou, China
2Institute of Blood and Marrow Transplantation, First Affiliated Hospital of Soochow University, Suzhou, China
3Jiangsu Key Laboratory of Clinical Immunology, First Affiliated Hospital of Soochow University, Suzhou, China
4Department of Endocrinology, Second Affiliated Hospital of Soochow University, Suzhou, China

Correspondence should be addressed to Chen Fang; moc.anis@1199afa and Cuiping Liu; moc.621@0891gnipiucuil

Received 12 December 2018; Revised 15 May 2019; Accepted 28 June 2019; Published 1 August 2019

Academic Editor: Ravirajsinh N. Jadeja

Copyright © 2019 Jingnan An et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jingnan An, Sisi Ding, Sicheng Li, et al., “Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D),” Journal of Immunology Research, vol. 2019, Article ID 1780567, 11 pages, 2019. https://doi.org/10.1155/2019/1780567.